Matches in Nanopublications for { ?s ?p "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP807100.RAlP3xtnIy_TiFUbhefMnNizymn6lwpRADyQwF4t2uK3g130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807100.RAlP3xtnIy_TiFUbhefMnNizymn6lwpRADyQwF4t2uK3g130_provenance.
- NP397134.RADx-Q0SLXbBeNjd8D28nAUUk9B2y_185O5ZlMktqCVLw130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397134.RADx-Q0SLXbBeNjd8D28nAUUk9B2y_185O5ZlMktqCVLw130_provenance.
- NP396774.RA_VXDzVcVBIHXUHmFjODtN22eNGPufXah4ePaljWjCqs130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396774.RA_VXDzVcVBIHXUHmFjODtN22eNGPufXah4ePaljWjCqs130_provenance.
- NP821157.RAISNGF5HSL7qymm4Rc7e6HYXIq8seW8q6i8zLtWpDr2A130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821157.RAISNGF5HSL7qymm4Rc7e6HYXIq8seW8q6i8zLtWpDr2A130_provenance.
- assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP625685.RA0PKSzwX7cM0Lsrrnqsh2M_YC8qqKF-Nhq4MQzJH_u0I130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625685.RA0PKSzwX7cM0Lsrrnqsh2M_YC8qqKF-Nhq4MQzJH_u0I130_provenance.
- NP625686.RAyYnXxtva-A4wkPnfqnm9iDOSYWV5Apop6NQPRB2GCnQ130_assertion description "[Studies have shown that two IgG FcgammaR polymorphisms (FCGR2A-H131R and FCGR3A-V158F) independently predict response to rituximab in patients with follicular lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625686.RAyYnXxtva-A4wkPnfqnm9iDOSYWV5Apop6NQPRB2GCnQ130_provenance.